Use of a botulinum toxin A in dentistry and oral and maxillofacial surgery
박경수, 이치헌, 이정우,
소속 상세정보
박경수 ( Park Kyung-Soo ) - Kyung Hee University School of Dentistry Department of Oral and Maxillofacial Surgery
이치헌 ( Lee Chi-Heun ) - Kyung Hee University School of Dentistry Department of Oral and Maxillofacial Surgery
이정우 ( Lee Jung-Woo ) - Kyung Hee University School of Dentistry Department of Oral and Maxillofacial Surgery
KMID : 0980320160160030151
Abstract
Botulinum toxin (BT) was the first toxin to be used in the history of human medicine. Among the eight known serotypes of this toxin, those currently used in medicine are types A and B. This review article mainly discusses BT type A (BTA) because it is usually used in dentistry including dental anesthesiology and oral and maxillofacial surgery. BTA has been used mainly in the treatment of temporomandibular joint disorder (TMD) and hypertrophy and hyperactivity of the masticatory muscles, along with being a therapeutic option to relieve pain and help in functional recovery from dental and oral and maxillofacial surgery. However, it is currently used broadly for cosmetic purposes such as reducing facial wrinkles and asymmetry. Although the therapeutic effect of BTA is temporary and relatively safe, it is essential to have knowledge about related anatomy, as well as the systemic and local adverse effects of medications that are applied to the face.
키워드
Botulinum toxin; Botulinum toxin; type A; Dentistry; Oral and Maxillofacial Surgeons
원문 및 링크아웃 정보
등재저널 정보